73346-79-9

Basic information

• Product Name: MUPIROCIN LITHIUM (100 MG)H0C176926UG/MG(AI)
• Synonyms: MUPIROCIN LITHIUM (100 MG)H0C176926UG/MG(AI);MUPIROCIN LITHIUM SALT;Lithium mupirocin;Lithium pseudomonate;9-((E)-4-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((1S,2S)-2-hydroxy-1-methyl-propyl)oxiranylmethyl]tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)nonanoic acid lithium salt;Pseudomonic acid A lithium salt;Li-MUP;Lithium mupirocin solution
• CAS NO: 73346-79-9
• Molecular Formula: C26H43O9.Li
• Molecular Weight: 506.558
• EINECS: 231-791-2
• Mol File: 73346-79-9.mol
• Article Data: 0

Chemical Properties

• Appearance: colorless or white/
• Storage Temp.: 2-8°C
• Solubility: H2O: soluble10mg/mL, clear, colorless
• Water Solubility: Soluble in water at approximately 10mg/ml
• CAS DataBase Reference: MUPIROCIN LITHIUM (100 MG)H0C176926UG/MG(AI)(CAS DataBase Reference)
• NIST Chemistry Reference: MUPIROCIN LITHIUM (100 MG)H0C176926UG/MG(AI)(73346-79-9)
• EPA Substance Registry System: MUPIROCIN LITHIUM (100 MG)H0C176926UG/MG(AI)(73346-79-9)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 73346-79-9(Hazardous Substances Data)

Usage

Description

MUPIROCIN LITHIUM (100 MG)H0C176926UG/MG(AI) is a semi-synthetic antibiotic derived from pseudomonic acid, an antibiotic complex produced by Pseudomonas fluorescens NCIB 10586. It is a lithium salt of mupirocin, which is a naturally occurring antibiotic. MUPIROCIN LITHIUM exhibits potent antibacterial activity, making it a valuable component in various applications.

Uses

Used in Pharmaceutical Industry:
MUPIROCIN LITHIUM (100 MG)H0C176926UG/MG(AI) is used as a topical antibacterial agent for the treatment of bacterial skin infections, particularly those caused by Staphylococcus aureus. Its application helps in reducing the bacterial load and promoting healing of the affected area.
Used in Research and Development:
MUPIROCIN LITHIUM (100 MG)H0C176926UG/MG(AI) is used in research studies to investigate mupirocin resistance in Staphylococcus aureus and its susceptibility to Mycoplasma species. This helps in understanding the mechanisms of resistance and developing strategies to overcome it, as well as assessing the effectiveness of mupirocin against different types of bacteria.